CVRx Stock

cvrx.comHealthcareFounded: 1900Funding to Date: $384.4MM

CVRx is the developer of a proprietary implantable technology for the treatment of high blood pressure and heart failure

Register for Details

For more details on financing and valuation for CVRx, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Nadim Yared
President, Chief Executive Officer & Board Member
John Brintnall
Chief Financial Officer
Jared Oasheim
Controller
Joseph DuPay
Senior Vice President, Development & Operations
Julia Stubben
Vice President, European Sales & Marketing
Dean Bruhn-Ding
Vice President of Regulatory Affairs and Quality Assurance

Board Members

Ali Behbahani MD
New Enterprise Associates
Claudia D'Augusta Ph.D
Ysios Capital
Geoff Pardo
Gilde Healthcare Partners
John Nehra
New Enterprise Associates
Joseph Slattery
Juan-Pablo Mas
Action Potential Venture Capital
Kadir Kadhiresan Ph.D
Johnson & Johnson Innovation - JJDC
Nadim Yared
Tom Heyman
Johnson & Johnson Innovation - JJDC

Other companies like CVRx in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$2.51B
Sector
Last Round Est. Valuation
$453MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$368.08MM
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$210.75MM
Sector
Last Round Est. Valuation
$265.75MM
Sector
Last Round Est. Valuation
$8.18B

News

Barostim device gets FDA nod to treat heart failure by stimulating nerve endings in the neck
/PRNewswire/ -- CVRx, Inc., a private medical device company, has secured equity financing totaling $93 million and a new $20 million debt facility. CVRx plans...